SLC2A3 promotes head and neck squamous cancer developing through negatively regulating CD8+ T cell in tumor microenvironment
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.SLC2A3 is upregulated in head and neck squamous cell carcinoma (HNSC), suppressing crucial CD8+ T cells and worsening patient survival. Reducing SLC2A3 boosts T cell activity and tumor elimination, offering a potential therapeutic target.
Area Of Science
- Oncology
- Immunology
- Molecular Biology
Background
- SLC2A3 (Solute Carrier Family 2, Member 3) is implicated in various cancers, but its role in head and neck squamous cell carcinoma (HNSC) is not well understood.
- The tumor microenvironment (TME) significantly influences HNSC progression and patient outcomes.
- CD8+ T cells are critical for anti-tumor immunity in HNSC.
Purpose Of The Study
- To investigate the prognostic significance of SLC2A3 in HNSC.
- To explore the impact of SLC2A3 on immune infiltration and the TME in HNSC.
- To elucidate the molecular mechanisms of SLC2A3 in CD8+ T cells and its effect on tumor progression.
Main Methods
- Bioinformatic analysis of TCGA HNSC cohort (n=504) using ESTIMATE, CIBERSORT, ssGSEA, and TIMER.
- Single-cell RNA sequencing analysis.
- Magnetic activated cell sorting (MACS) and flow cytometry for CD8+ T cell isolation and characterization.
- Gene Set Enrichment Analysis (GSEA) and Western Blot (WB).
- In vitro co-culture system of CD8+ T cells and TU686 tumor cells.
Main Results
- SLC2A3 upregulation correlates with poor prognosis and altered immune infiltration in HNSC.
- SLC2A3 expression is enriched in immune-related processes and suppresses CD8+ T cell function.
- Overexpressed SLC2A3 in CD8+ T cells may induce ferroptosis, promoting tumor progression.
- SLC2A3 knockdown enhances CD8+ T cell proliferation and anti-tumor cytotoxicity.
Conclusions
- SLC2A3 is a potential risk gene in HNSC, associated with immune evasion and adverse clinical outcomes.
- Targeting SLC2A3 in CD8+ T cells may represent a novel therapeutic strategy for HNSC by restoring anti-tumor immunity.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...